Event / Health

Polypropylene Hernia Mesh Lawsuits

← All events

Updated

Multiple lawsuits are being prepared against manufacturers of polypropylene anti-hernia implants in France, with lawyers planning to file at least 500 complaints by June 2026. Patients report severe complications from the mesh implants, while medical societies maintain the devices remain safe when properly used.

2 reported locations
Geography of the reported facts
  1. Paris, France
  2. France

The story so far

Daily activity

0 articles
0 articles

2026-08-19 to 2026-11-16 · UTC publication dates

Coverage begins 28 Mar, 09:37 UTC

Follow the documented timeline or explore the related reporting.

What happened

The facts
  1. Second lawyer has collected approximately 30 additional complaints over hernia implants

    Attorney Philippe Courtois, representing Arnaud Denis, has independently collected approximately 30 complaints which he plans to file with the Paris public prosecutor in the coming weeks. Courtois hopes for the opening of a formal judicial investigation into the matter.

    1 corroborating report

  2. International medical societies maintain hernia implant mesh remains recommended treatment

    The European Hernia Society and HerniaSurge Group continue to recommend prosthetic implant (mesh) placement as the reference technique for hernia repair. Medical authorities state this technique maintains a favorable risk-benefit ratio. Over 250,000 patients undergo abdominal wall surgery annually. Side effects are known to occur in 5 to 10 percent of patients and are disabling in 1 to 5 percent of cases. Common complications include post-operative pain at the surgical site, while surgical site infections are rare.

    1 corroborating report

  3. Actor Arnaud Denis files first complaint over polypropylene hernia implant complications

    On January 5, actor Arnaud Denis, age 42, filed the first complaint with the Paris public prosecutor against unknown parties for involuntary injury related to polypropylene hernia implants. Denis has been raising awareness of adverse effects from these implants since 2023. He is currently hospitalized in palliative care in Belgium since March 18, having chosen to pursue euthanasia procedures due to the severity of his condition. His complaint is under analysis at the public prosecutor's health division.

    1 corroborating report

  4. French surgical society states no evidence of immune-mediated material intolerance syndrome from hernia mesh

    The French Society for Parietal Surgery and Hernia Club (SFCP-CH) stated in April 2025 that while some cases of syndrome with non-specific symptoms such as fatigue, diffuse pain, and inflammatory markers have been reported, there is to date no demonstration in medical literature of the existence of an immune-mediated material intolerance syndrome involving hernia implants. The society notes that in most cases, removal of the prosthetic material, which is highly damaging to tissue, did not result in healing.

    1 corroborating report

  5. Hernia implant mesh controversy raises patient anxiety about surgical treatment

    Following media coverage of what victims characterize as a health scandal, an increasing number of patients requiring hernia surgery have become anxious about implantation. Some patients are declining or postponing surgery, which concerns physicians. Postponing hernia repair exposes patients to potential dangerous consequences, including the possibility of emergency surgery for strangulated hernia requiring more invasive surgical procedures than standard hernia repair.

    1 corroborating report

  6. Lawyer plans to file at least 500 complaints over anti-hernia implants by end of June

    Pierre Debuisson, a lawyer specializing in class action lawsuits, announced plans to file at least 500 complaints and expert reports with the Paris public prosecutor's health division by the end of June. As of late 2025, he had collected 350 complaints. The complaints will be filed in multiple series alleging involuntary injury, aggravated fraud, and involuntary homicide. Debuisson is also preparing litigation against US manufacturers for defective products, seeking compensation between 100,000 and 1 million euros per victim.

    1 corroborating report

Read the coverage